Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions
Roots Analysis has announced the addition of the "Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions.
By: Roots Analysis
The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains.
To order this 420+ page report, which features 150+ figures and 350+ tables, please visit this link
Key Market Insights
Over 160 software-enabled supply chain management systems are currently available
Of these, more than 25% are inventory management systems (IMS), which are primarily used for tracking inventory, orders, sales and deliveries. Examples include (in alphabetical order) ATiM Software, Benchling Inventory, CryoTrackIMS, Cryotrax, CTM-STAR ™, Lynx Mobile®, Mosaic FreezerManagement, and Stafa Apheresis.
~ 80% of marketed solutions are used in collection centers and sample storage warehouses
Further, about 49% of such systems are being implemented to streamline manufacturing operations of cell and advanced therapies
Cloud-based deployment is gradually gaining popularity
Stakeholders claim that such deployment methods can be rapidly provisioned with minimal management effort (often over the internet), allowing for faster implementation. At present, about 47% of the software systems are being deployed via cloud; examples include (in alphabetical order) Chronicle ™ automation software, Cryoportal®, evo.is®, PAS-X MES, STARLIMS, tempmate®-CLOUD, and TrakCel ™.
Around 57% of the stakeholders in this industry are based in the US
This can be attributed to the increasing interest in cell and advanced therapies in this region, making North America the current hub of innovation in this field. It is followed by players in the EU (35%) and Asia Pacific (8%).
2,600+ tweets focused on the increasing interest and ongoing efforts of industry stakeholders
Social media analysis revealed that many biopharmaceutical developers are adopting software-enabled supply chain management solutions with increasing enthusiasm. In fact, many of the tweets were related to the ability of such systems to resolve the challenges associated with large volumes of supply chain data.
For additional details, please visit
+1 (415) 800 3415
+44 (122) 391 1091